CS Professional · Intellectual Property Rights - Law and Practice · Indian Patent Law and its Developments
The Controller grants Gamma Biotech a compulsory licence under section 84 of the Patents Act, 1970 for a patented vaccine. Gamma Biotech asks that the licence (i) be exclusive, (ii) allow it to import the vaccine freely from its overseas plant, and (iii) be assignable. Which statement best reflects the Controller's duties under section 90?
The Controller must endeavour to make the licence non-exclusive and non-assignable. A compulsory licence cannot authorise import that would otherwise infringe, though the Central Government may, in public interest, direct the Controller to authorise import on conditions such as royalty, quantum, price and period.
- AAll three requests can be met if royalty is reasonable
- BThe Controller must endeavour to secure a non-exclusive, non-assignable licence, and the licence cannot authorise import that would infringe unless the Central Government directs it in public interestCorrect
- COnly the assignability request must be refused; exclusivity and import are at the Controller's discretion
- DThe licence must be exclusive for the balance term, but import is barred absolutely
Explanation
Section 90(1)(iv) and (v) require endeavouring to secure that the licence is non-exclusive and the licensee's right non-assignable. Section 90(2) bars authorising import that would otherwise infringe, but 90(3) lets the Central Government, in public interest, direct the Controller to authorise import. Option D wrongly says import is barred absolutely.
Did you get it right without looking?
One question tells you little. A timed set on Indian Patent Law and its Developments shows your real accuracy, how long you take and where you lose marks.
More Indian Patent Law and its Developments questions
- Kabir and Dev run a partnership firm advising on patents. Kabir is a registered patent agent but Dev is not. The firm prepares patent specif…
- The Controller sends Anil Dyes Ltd its first statement of objections on its application. The company cures some objections, but the Controll…
- Kiran Industries made a first application in Country X on 5 January 2025 and a second for similar protection in Country Y on 20 March 2025, …
- Zenith Pharma Ltd, Hyderabad, holds an Indian patent on a cardiac drug. Before the patent expires, Kiran Labs makes small batches of the dru…
- Dhruv Tech holds an exclusive licence under a patent owned by Evergreen Ltd. After the date of the licence, Fulcrum Ltd infringes the patent…
- Arjun reads the present Section 162 and looks for sub-sections (2) and (3). What does the official text show about them?